lncRNA PVT1 upregulates KLF12 by competing with miR-484 to promote the progression of cervical cancer via the IL-6/STAT3 signaling pathway

BAO Ke-yong, WANG Dong, BAO Li-hong, ZHANG Li, ZHANG Xue, TAO Xiao-yu, GAO Han

PDF(16380 KB)
Welcome to Current Immunology, Today is
PDF(16380 KB)
Current Immunology ›› 2025, Vol. 45 ›› Issue (2) : 151.

lncRNA PVT1 upregulates KLF12 by competing with miR-484 to promote the progression of cervical cancer via the IL-6/STAT3 signaling pathway

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 45(2): 151

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(16380 KB)

Accesses

Citation

Detail
Sections
Recommended
Contact
Add: 1 / f, library 1, no.280, south chongqing road, Shangha
Code: 200025
Tel: 021-53062055
E-mail: currentimmunol@126.com
visited
Total visitors:
Visitors of today:
Now online:
Copyright © 2022 Current Immunology

/

〈 〉